EpistrySign in
LimitedMetadata only — full assessment not yet run

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

John M. Ringman, Sally A. Frautschy, Edmond Teng, Aynun N. Begum, Jenny Bardens, Maryam Beigi, Karen H. Gylys, Vladimir Badmaev, Dennis D. Heath, Liana G. Apostolova, Verna R. Porter, Zeba Vanek, Gad A. Marshall, Gerhard Hellemann, Catherine A. Sugar, Donna Masterman, Thomas J. Montine, Jeffrey L. Cummings, Greg M. Cole · Alzheimer s Research & Therapy · 2012

DOI 10.1186/alzrt146

Why this label

  • Metadata only — full assessment not yet run.

The Paper Scorecard

  • Standingclear
    • No retraction on record (OpenAlex metadata as of 2026-07-03).
  • Designjournal article
    • Journal article (Alzheimer s Research & Therapy). Study design detail comes from the methodology read, not metadata.
  • Executionnot assessed
    • Metadata only — full assessment not yet run.
  • Corroborationhighly cited
    • Cited by 530 works (OpenAlex citation count).
  • Provenanceidentified
    • Published in Alzheimer s Research & Therapy.
    • Publisher: BioMed Central.
    • ISSN 1758-9193.
    • The journal is listed in DOAJ.
    • Open-access status: gold.
Assessed by Epistry · metadata as of July 3, 2026
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a… — Epistry